Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS

Ítems similars

• Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
  per: Jones, R, et al.
  Publicat: (2010)
• Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial
  per: Harper, L, et al.
  Publicat: (2009)
• Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
  per: Harper, L, et al.
  Publicat: (2012)
• Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
  per: Roberta Fenoglio, et al.
  Publicat: (2020-10-01)
• Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
  per: Frank B. Cortazar, et al.
  Publicat: (2018-03-01)